Cargando…

Baseline splenic volume as a biomarker for clinical outcome and circulating lymphocyte count in gastric cancer

BACKGROUND: The spleen is the largest peripheral lymphoid organ in the body. Studies have implicated the spleen in the development of cancer. However, it is unknown whether splenic volume (SV) is associated with the clinical outcome of gastric cancer. METHODS: Data of gastric cancer patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Ziyang, Liu, Zhen, Li, Jie, Sun, Juan, Ma, Mingwei, Ye, Xin, Yu, Jianchun, Kang, Weiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923954/ https://www.ncbi.nlm.nih.gov/pubmed/36793344 http://dx.doi.org/10.3389/fonc.2022.1065716

Ejemplares similares

The Immune Microenvironment in Gastric Cancer: Prognostic Prediction
por: Ma, Mingwei, et al.
Publicado: (2022)

Comparison Among Endoscopic, Laparoscopic, and Open Resection for Relatively Small Gastric Gastrointestinal Stromal Tumors (<5 cm): A Bayesian Network Meta-Analysis
por: Liu, Zhen, et al.
Publicado: (2021)

Folate receptor-positive circulating tumor cell count, lymphocyte count and derived neutrophil-to- lymphocyte ratio for diagnosing lung cancer relapse
por: Wang, Huanrong, et al.
Publicado: (2023)

The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer
por: Sun, Juan, et al.
Publicado: (2021)

The Role and Mechanism of microRNA-1224 in Human Cancer
por: Ma, Mingwei, et al.
Publicado: (2022)

OTUB2 regulates KRT80 stability via deubiquitination and promotes tumour proliferation in gastric cancer
por: Ouyang, Siwen, et al.
Publicado: (2022)

Correction: OTUB2 regulates KRT80 stability via deubiquitination and promotes tumour proliferation in gastric cancer
por: Ouyang, Siwen, et al.
Publicado: (2022)

Comparison of Prognosis Between Microscopically Positive and Negative Surgical Margins for Primary Gastrointestinal Stromal Tumors: A Systematic Review and Meta-Analysis
por: Liu, Zhen, et al.
Publicado: (2022)

Corrigendum: Comparison of prognosis between microscopically positive and negative surgical margins for primary gastrointestinal stromal tumors: A systematic review and meta-analysis
por: Liu, Zhen, et al.
Publicado: (2023)

Neutrophil-Lymphocyte Ratio and Circulating Tumor Cells Counts Predict Prognosis in Gastrointestinal Cancer Patients
por: Qian, Chengcheng, et al.
Publicado: (2021)

Comprehensive analysis of cuproptosis-related immune biomarker signature to enhance prognostic accuracy in gastric cancer
por: Li, Jie, et al.
Publicado: (2023)

Comparisons of nutritional status and complications between patients with and without postoperative feeding jejunostomy tube in gastric cancer: a retrospective study
por: Li, Kang, et al.
Publicado: (2023)

Perioperative Enteral Immunonutrition Support for the Immune Function and Intestinal Mucosal Barrier in Gastric Cancer Patients Undergoing Gastrectomy: A Prospective Randomized Controlled Study
por: Ma, Mingwei, et al.
Publicado: (2023)

Tumour‐associated macrophages in gastric cancer: From function and mechanism to application
por: Li, Jie, et al.
Publicado: (2023)

PDK4 Constitutes a Novel Prognostic Biomarker and Therapeutic Target in Gastric Cancer
por: Zhang, Zimu, et al.
Publicado: (2022)

Integrated analysis from multicentre studies identities m7G-related lncRNA-derived molecular subtypes and risk stratification systems for gastric cancer
por: Ma, Mingwei, et al.
Publicado: (2023)

Splenic Volume, an Easy-To-Use Predictor of HCC Late Recurrence for HCC Patients After Hepatectomy
por: Fang, Tongdi, et al.
Publicado: (2022)

Could circulating biomarkers of nitrosative stress and protein glycoxidation be useful in patients with gastric cancer?
por: Dorf, Justyna, et al.
Publicado: (2023)

Diagnostic significance and utility of circulating redox biomarkers in patients with gastric cancer – preliminary study
por: Dorf, Justyna, et al.
Publicado: (2023)

Associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia
por: Sitlinger, Andrea, et al.
Publicado: (2022)

Low Multiplication Value of Absolute Monocyte Count and Absolute Lymphocyte Count at Diagnosis May Predict Poor Prognosis in Neuroblastoma
por: Tamura, Akihiro, et al.
Publicado: (2020)

Higher Levels of Pre-operative Peripheral Lymphocyte Count Is a Favorable Prognostic Factor for Patients With Stage I and II Rectal Cancer
por: Zhang, Ying-Ying, et al.
Publicado: (2019)

Mean Platelet Volume/Platelet Count Ratio and Risk of Progression in Glioblastoma
por: Wach, Johannes, et al.
Publicado: (2021)

Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab
por: Incorvaia, Lorena, et al.
Publicado: (2023)

Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma
por: Aarnink, Anne, et al.
Publicado: (2018)

Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma
por: Niogret, Julie, et al.
Publicado: (2020)

The Role of Contrast-Enhanced Ultrasound in Differentiating Splenic Tuberculosis From Splenic Lymphoma
por: Zhang, Wenzhi, et al.
Publicado: (2022)

Prognostic Significance of Baseline Neutrophil Count and Lactate Dehydrogenase Level in Patients With Esophageal Squamous Cell Cancer Treated With Radiotherapy
por: Luo, He-San, et al.
Publicado: (2020)

The combination of baseline neutrophil to lymphocyte ratio and dynamic changes during treatment can better predict the survival of osteosarcoma patients
por: Li, Longqing, et al.
Publicado: (2023)

Low lymphocyte count and high monocyte count predicts poor prognosis of gastric cancer
por: Feng, Fan, et al.
Publicado: (2018)

Gastric Varices in Absence of Splenic Vein Thrombosis: A Rare Entity of Idiopathic Non-Cirrhotic Portal Hypertension
por: Choksi, Vivek, et al.
Publicado: (2017)

A Composite Biomarker of Derived Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio Correlates With Outcomes in Advanced Gastric Cancer Patients Treated With Anti-PD-1 Antibodies
por: Pan, Yuting, et al.
Publicado: (2022)

Tumor-Infiltrating Lymphocyte-Based Risk Score for Predicting Prognosis in Gastric Cancer
por: Xie, Siyuan, et al.
Publicado: (2020)

A Pilot Study of Baseline Spatial Genomic Heterogeneity in Primary Gastric Cancers Using Multi-Region Endoscopic Sampling
por: Chao, Joseph, et al.
Publicado: (2020)

The Role of Circulating Biomarkers in Lung Cancer
por: Herath, Sayuri, et al.
Publicado: (2022)

Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients
por: Wang, Xin, et al.
Publicado: (2020)

Establishment of the Radiologic Tumor Invasion Index Based on Radiomics Splenic Features and Clinical Factors to Predict Serous Invasion of Gastric Cancer
por: Pan, Bujian, et al.
Publicado: (2021)

Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
por: Wang, Huan, et al.
Publicado: (2020)

Corrigendum: Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients
por: Wang, Xin, et al.
Publicado: (2021)

Hospitalized cancer patients with comorbidities and low lymphocyte counts had poor clinical outcomes to immune checkpoint inhibitors
por: Young, Richard Benjamin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_165uouos863e19knbr471g2qvl